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Abstract 
We investigated the presence of β-adrenoceptor subtypes in human urinary bladder 
urothelium and examined whether β-adrenoceptors in the urothelium modulate the 
relaxation responses of isolated human detrusor strips to a β-adrenoceptor agonist. 
Expression of β1-, β2- and β3-adrenoceptor mRNA in urothelium and detrusor smooth 
muscle was determined by reverse transcription-polymerase chain reaction (RT-PCR), and 
the distribution of β1-, β2- and β3-adrenoceptors in human urinary bladder urothelium was 
examined by immunohistochemistry. Paired human longitudinal detrusor strips with and 
without an intact urothelium were suspended in organ baths to construct 
concentration-response curves to isoproterenol. The possible involvement of 
urothelium-derived nitric oxide (NO) in this response was examined in additional 
experiments with urothelium-intact strips in the presence of NG-nitro-L-arginine 
methylester (L-NAME). Results confirmed the expression of β1-, β2- and β3-adrenoceptors 
in the human urinary bladder urothelium. Further, the presence of the urothelium caused a 
parallel rightward shift of the concentration-response curve to isoproterenol, with a 
significant reduction in potency (pEC50). L-NAME failed to exert any significant effect on 
the relaxation response to isoproterenol in the urothelium-intact strips. These results 
confirm the presence of β1-, β2- and β3-adrenoceptors in human urinary bladder urothelium. 
Further, they suggest that urothelial β-adrenoceptors induce the release of a 
urothelium-derived factor which inhibits the β-adrenoceptor agonist-induced relaxation of 
the human detrusor smooth muscle, and that this inhibitory mechanism might not involve 
NO. 
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Introduction 
 
Although the urothelium of the urinary bladder has been regarded as a passive barrier 
which protects the underlying detrusor smooth muscle from various substances in urine, 
recent findings suggest that the urothelium is actively involved in the regulation of bladder 
function (de Groat 2004). Evidence for this comes from findings that urothelial cells 
express various receptors such as muscarinic receptors, transient receptor potential 
vanilloid subtype 1 (TRPV1), adrenoceptors and purinoceptors, thereby allowing them to 
respond to mechanical, chemical and other stimuli (Hawthorn et al. 2000; Birder et al. 1998, 
2002; Elneil et al. 2001). Further, urothelial release of neurotransmitters such as nitric oxide 
(NO), Ach and ATP is thought to stimulate suburothelial afferent nerves directly or via 
myofibroblasts (Birder et al. 2002; Yoshida et al. 2004; Ferguson et al. 1997; Fry et al. 
2004).  
Multiple lines of evidence suggest that β-adrenoceptors are abundant in the detrusor 
smooth muscle of the urinary bladder, and play important roles in detrusor relaxation 
during urinary storage in various species (Lefkowitz et al. 1996; Longhurst and 
Levendusky 1999; Fujimura et al. 1999; Takeda et al. 1999; Igawa et al. 1999, 2001). 
β-Adrenoceptors are now subclassified into β1-, β2- and β3-adrenoceptor subtypes, with the 
predominant subtype in the urinary bladder differing among species. In humans, the 
β3-adrenoceptor is predominantly responsible for detrusor relaxation (Fujimura et al. 1999; 
Takeda et al. 1999; Igawa et al. 1999, 2001), giving rise to the notion that β3-adrenoceptor 
agonists may be highly promising agents for the treatment of overactive bladder (OAB). 
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Recent studies indicate that β-adrenoceptors may also be present in the urothelium of 
the urinary bladder. In rats, β-adrenoceptor stimulation is associated with activation of the 
adenylate cyclase pathway in bladder epithelial cells, leading to the initiation of an increase 
in intracellular Ca2+ concentration which in turn triggers NO production and its release 
(Birder et al. 1998, 2002). Using porcine isolated detrusor strips, Murakami and colleagues 
demonstrated that contractile responses to carbachol were inhibited by stimulating 
urothelial β-adrenoceptors (Murakami et al. 2007), leading them to conclude that 
β-adrenoceptor agonists might stimulate the urothelial release of an unidentified factor 
which inhibits contractions of the detrusor smooth muscle. These findings suggest that 
urothelial β-adrenoceptors directly or indirectly influence the function of the detrusor 
smooth muscle. However, the molecular biological and functional roles of β-adrenoceptors 
in the urothelium of the human urinary bladder have not been reported.  
Here, we investigated the expression of β-adrenoceptor subtypes, particularly 
β3-adrenoceptors, in human urinary bladder urothelium by reverse transcription-polymerase 
chain reaction (RT-PCR) and immunohistochemistry. In addition, using an in vitro 
functional technique, we also determined whether stimulation of urothelial β-adrenoceptors 
modulates the relaxant effect of β-adrenoceptor agonists on detrusor smooth muscle in 
humans, and furthermore verified whether this relaxant effect is modulated by 
β-adrenoceptor stimulation-induced NO release from the urothelium.
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Methods 
 
Patients and specimens 
 
Human urinary bladder specimens were collected from 13 patients (8 men and 5 women; 
aged 66.2 ± 6.7, age range 57–80 years) undergoing total cystectomy for bladder carcinoma. 
All patients were screened by their physician as having no evidence of overactive bladder 
or bladder outlet obstruction. Exclusion criteria included previous pelvic radiotherapy, 
extensive chemotherapy or current urinary tract infection. None of the patients had diseases 
or used medications known to interfere with the β-adrenoceptors system. Written informed 
consent was obtained from all patients. The study was approved by the ethics committee of 
Hamamatsu University School of Medicine. 
All specimens were obtained from macroscopically normal tissue in the anterior or 
lateral wall of the urinary bladder body via a longitudinal incision. They were immediately 
placed in pre-oxygenated Krebs’ solution (composition in mM: NaCl 118.1, KCl 4.7, 
NaHCO3 25.0, KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5 and glucose 11.7) at 4 °C and 
transported to the laboratory. After removal of the adventitia and connecting fatty tissues, 
the specimens were cut into paired longitudinal detrusor strips measuring approximately 
15×5×5 mm for functional studies. For molecular studies, residual detrusor and urothelial 
tissues were separately cut into portions weighing approximately 100 mg and immediately 
frozen in liquid nitrogen. They were then stored at -80 °C until RNA was extracted (see 
below).  
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RT-PCR 
 
Expression of β1-, β2- and β3-adrenoceptor mRNA was independently examined by region 
in five detrusor and urothelium specimens (four men and one woman, age range 63–74 
years). Total RNA was extracted using the TRIzol Reagent according to the manufacturer’s 
instructions. The amount of total RNA was determined with a spectrophotometer (UV-2450, 
Shimadzu, Kyoto, Japan), and only good quality samples were used for RT–PCR.  
Expression of mRNA for α-smooth muscle actin (α-SMA), a smooth muscle marker, 
was examined in each specimen independently to confirm the separation of detrusor smooth 
muscle and urothelium. Expression of α-SMA gene transcripts was examined by RT-PCR in 
accordance with a previous report, with an expected PCR product size of 965 bp (Ueda et al. 
2002). Expression of mRNA for α-SMA was high in detrusor smooth muscle RNA, but 
markedly low or undetectable in urothelium RNA (Fig. 1f). 
Expression of β-adrenoceptor subtype transcripts in human detrusor smooth muscle 
and urothelium was determined by RT-PCR using the GeneAmp PCR System 9700 
(Applied Biosystems, Tokyo, Japan). In the RT step, 2 µg of total RNA was mixed with the 
RT reagent mixtures to a final volume of 20 µl. The RT reagent mixtures consisted of 5 x 
RT buffer (20 mM Tris-HCl pH 8.0, 100 mM KCl, 2 mM MgCl2), 10 mM dNTP, 2.5 ng 
random hexamer, 0.1 M DTT and 40 U RNase Out. Next, 200 U SuperScript III RT was 
added and the mixtures were incubated at 25 °C for 10 min, followed by additional 
incubation at 50 °C for 60 min. Samples were heated at 70 °C for 10 min to terminate the 
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reverse transcription and then stored at 4 °C until use (RT-Mixture). In the PCR step, the 
RT-Mixture (1 µl) was mixed with the PCR reagent mixtures to a final volume of 20 µl. 
The PCR reagent mixtures consisted of 10 x PCR buffer (20 mM Tris-HCl pH 8.3, 100 mM 
KCl, 2 mM MgCl2), 0.5 µM sense primer, 0.5 µM antisense primer, 0.8 mM dNTPs, 2 mM 
MgSO4 and 0.5 U Tac DNA polymerase.  
Sequences of the sense and anti-sense primers for β1-, β2- and β3-adrenoceptors were 
used according to a previous report (Krief et al. 1993), and a pair of primers for β-actin as 
internal standard was designed based on a DNA sequence. The primer sequences for β1-, β2-, 
β3-adrenoceptors and β-actin are shown in Table 1.  
The PCR reaction of β-adrenoceptor subtypes was conducted at 96 °C for 3 min and 40 
cycles of 96 °C for 30 s, 57 °C for 15 s and 72 °C for 30 s (for β1) or 20 s (for β2 and β3), 
followed by a final extension at 72 °C for 5 min. PCR products (8 µl) were visualized by 
electrophoresis on 3.0% agarose gels with ethidium bromide. To rule out the possibility of 
amplifying genomic DNA, PCR was performed with no prior RT of the RNA in all 
experiments. The specificity of the primers and authenticity of the corresponding PCR 
products were verified by digestion of PCR products with specific restriction enzymes. 
β1-Adrenoceptor PCR products were digested with Rsa I (generated fragments of 67 and 
198 bp); β2-adrenoceptor with Rsa I (93 and 236 bp); and β3-adrenoceptor with Apa I (123 
and 191 bp).  
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Immunohistochemistry 
 
For immunohistochemistry, paraffin sections (4 µm) of archival human surgical resection 
specimens of the urinary bladder obtained from six different patients (four men and two 
women, age range 59–79 years) were immunostained using the HistoFine SimpleStain 
Max-PO kit (Nichirei Bioscience, Tokyo, Japan). The tissues were composed of 
full-thickness sections of human urinary bladder wall taken from macroscopically and 
histologically normal areas of formalin-fixed specimens removed for bladder carcinoma.  
Deparaffinized and rehydrated sections were pretreated to unmask epitopes (β1- and 
β2-adrenoceptor, microwave 15 min at 500 W in 10 mmol/L citrate buffer, pH 6.0; 
β3-adrenoceptor, pepsin treatment for 20 min at room temperature), and to block 
endogenous peroxidase activity (3% H2O2 in methanol for 15 min at room temperature). 
After incubation with primary antibodies for β1-adrenoceptor (polyclonal rabbit antibody 
diluted 1:50, Santa Cruz Biotechnology, California, USA; incubated overnight at 4 °C), 
β2-adrenoceptor (polyclonal rabbit antibody diluted 1:50, Affinity BioReagents, Colorado, 
USA; incubated overnight at 4 °C), and β3-adrenoceptor (polyclonal rabbit antibody diluted 
1:50, TransGenic Inc., Hyogo, Japan; incubated for 60 min at room temperature), the slides 
were incubated with secondary antibodies (HistoFine SimpleStain Max-PO kit) for 30 min. 
The antigen-antibody reaction was visualized with 0.01% 3,3’-diaminobenzidine 
tetrahydrochloride (Dako Envision kit/HRP (DAB), Dako Japan, Kyoto, Japan). All 
sections were counterstained with Mayer’s hematoxylin and mounted under coverslips. For 
each section, a negative control consisted of primary incubation with affinity-purified rabbit 
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IgG fraction (Dako Japan) at an equivalent protein concentration. Immunohistochemical 
staining of β1-, β2-, and β3-adrenoceptors was recorded as positive or negative, with a 
sample considered negative when immunostaining was the same as that of the negative 
control. 
 
Functional studies 
 
Paired longitudinal strips (approximately 15×5×5 mm) of detrusor smooth muscle were 
isolated from the human bladder. The urothelium was carefully removed from one strip per 
pair. The strips were then suspended in 10-ml organ baths containing Krebs’ solution 
(composition as above) maintained at 37 °C and gassed with 95% O2 - 5% CO2. One end of 
each strip was connected to a force-displacement transducer (TB-651T, Nihon Kohden, 
Tokyo, Japan) coupled to an amplifier system (EF-601G, Nihon Kohden, Tokyo, Japan), 
and changes in detrusor tension were recorded on a PowerLab data acquisition system 
using Chart software (AD Instruments Japan, Tokyo, Japan). The strips were gradually 
stretched until a stable resting tension of 1.0 g was obtained, and equilibrated for at least 60 
min. During equilibration, the organ bath solution was changed every 10-15 minutes. After 
resting tension was stabilized at 1.0 g, concentration-response curves to isoproterenol, a 
non-selective β-adrenoceptor agonist, were constructed by cumulatively increasing drug 
concentration at 10-15 min intervals. One response curve was generated per preparation. 
All experiments were conducted in the presence of phentolamine (1 µM), a non-selective 
α-adrenoceptor antagonist, to eliminate the involvement of α-adrenoceptors.  
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In some experiments with an intact urothelium, basal concentration-response curves 
were drawn in the presence of 100 µM NG-nitro-L-arginine methylester (L-NAME), a NO 
synthase inhibitor, for 30 min before constructing the concentration-response curve to 
isoproterenol. After cumulative application of isoproterenol, 10 µM forskolin was added to 
the organ bath. 
 
Analysis of functional data 
 
Results are presented as mean values ± standard error of mean (SEM). The relaxant effect 
of isoproterenol was expressed as a percentage of the maximal relaxation (100%) induced 
by 10 µM forskolin, which was used as a reference drug. Mean concentration-response 
curves to isoproterenol were analyzed by fitting the data to a four-parameter logistic 
equation using non-linear regression with GraphPad Prism software (GraphPad, California, 
USA). Agonist potency (pEC50, negative logarithm of the concentration giving 
half-maximal effect) and the maximal relaxation responses were also determined using this 
software. Relaxation responses and pEC50 were compared using Student’s t-test, with a P 
value of less than 0.05 considered statistically significant.  
 
Drugs 
 
All molecular reagents, including TRIzol Reagent, random hexamer, SuperScript III RT and 
Tac DNA polymerase, were obtained from Invitrogen Life Technologies (Carlsbad, 
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California, USA). Phentolamine hydrochloride, (±)-isoproterenol hydrochloride, L-NAME 
and forskolin were purchased from Sigma Chemical Co. (St. Louis, Missouri, USA). 
Forskolin was dissolved in dimethyl sulfoxide, and all other drugs in distilled water. 
Reported concentrations were the final concentrations in the organ-bath solution. 
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Results 
 
Expression of β-adrenoceptor subtype mRNA in the human urinary bladder 
urothelium 
 
Expression of β1-, β2- and β3-adrenoceptor mRNA in human detrusor smooth muscle and 
urothelium was examined using RT-PCR. PCR products for β1-, β2- and β3-adrenoceptors 
were detected in all preparations of both tissues, with the expected size of PCR products of 
265, 329 and 314 bp, respectively (Fig. 1a,b). PCR product for β-actin as an internal 
standard was also detected in all preparations with an expected size of 353 bp. Further, PCR 
products without prior RT of the RNA revealed no positive bands. Using specific restriction 
enzymes, β1-adrenoceptor PCR products were digested with Rsa I (generated fragments of 
67 and 198 bp), β2-adrenoceptor with Rsa I (93 and 236 bp) and β3-adrenoceptor with Apa I 
(123 and 191 bp) (Fig. 1c-e).  
 
Distribution of β-adrenoceptor subtypes in the human urinary bladder urothelium 
 
On immunohistochemistry, urothelial cells stained positively for the presence of β1-, β2- 
and β3-adrenoceptor (Fig. 2a-c). Positive staining for β1-, β2- and β3-adrenoceptor was also 
identified in detrusor smooth muscle cells, but only weakly for β1- and β2-adrenoceptor (Fig. 
2d-f). No staining of the negative control was seen in any section of either urothelial cells 
or detrusor smooth muscle cells (Fig. 2g,h).   
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Relaxation responses of detrusor strips with and without an intact urothelium to 
isoproterenol 
 
Isoproterenol, a non-selective β-adrenoceptor agonist, produced significant 
concentration-dependent relaxation of the human detrusor strips both with and without an 
intact urothelium (Fig. 3). The presence of the urothelium caused a parallel rightward shift 
of the concentration-response curve to isoproterenol (Fig. 4), showing that the 
urothelium-intact detrusor strips were significantly less sensitive to isoproterenol than the 
urothelium-denuded strips (pEC50 value 5.58 ± 0.30 vs. 6.31 ± 0.23, p < 0.01). Nevertheless, 
maximal relaxation responses to isoproterenol were similar, at 80.4 ± 3.2% for the intact 
and 84.2 ± 3.4% for the denuded strips. L-NAME, a NO synthase inhibitor, exerted no 
significant effect on the relaxation responses of the intact strips to isoproterenol, with a 
pEC50 value of 5.93 ± 0.40 and maximal relaxation response of 83.2 ± 8.3% compared to 
the control (Fig. 5). 
 15
Discussion 
 
Here, we used RT-PCR to provide evidence for the expression of β1-, β2- and 
β3-adrenoceptor mRNA in human urinary bladder urothelium, and immunohistochemistry 
to identify the distribution of β1-, β2- and β3-adrenoceptors in human urinary bladder 
urothelial cells. We also showed that the presence of an intact urothelium reduces the 
relaxant effects of isoproterenol on human detrusor strips. These findings confirm the 
presence of β-adrenoceptors in human urothelium, and support the notion that urothelial 
β-adrenoceptors play an active role in the regulation of bladder functions. 
Support for a role of the urothelium in the modulation of bladder function has come 
from a number of molecular biological and functional studies. Detrusor contractions 
elicited by tachykinins in guinea pig and canine urinary bladder were strongly inhibited 
after removal of the mucosa (Maggi et al. 1987; Saban et al. 1992). Stimulation of 
urothelial α1D-adrenergic receptors in rat bladder facilitated mechanosensitive bladder 
afferent nerve activity and the micturition reflex (Ishihama et al. 2006). Likewise, many 
populations of muscarinic receptors exist in the porcine and human urothelium and 
stimulation of the urothelium by carbachol causes the release and transfer of an unknown 
urothelium-derived factor, resulting in the inhibition of detrusor strip contractions 
(Hawthorn et al. 2000; Templeman et al. 2002; Chaiyaprasithi et al. 2003). 
Although β3-adrenoceptors are known to be abundant in the detrusor smooth muscle 
and play a key role in relaxation of the human urinary bladder via the activation of 
adenylate cyclase during urine storage, little is known about the expression of 
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β-adrenoceptor subtypes in the human urinary bladder urothelium. Harmon and colleagues 
identified the presence of β-adrenoceptors on immortalized human urothelial cell 
membranes, but not the specific subtype involved (Harmon et al. 2005). To our knowledge, 
the present study is the first to report the presence of β1-, β2- and β3-adrenoceptors in human 
urinary bladder urothelium by RT-PCR and immunohistochemistry. While previous reports 
have demonstrated the distribution of mucosal β3-adrenoceptor mRNA in human small 
intestine, stomach and colon using RT-PCR and immunohistochemical techniques 
(Anthony et al. 1998; Roberts SJ et al. 1997), their functional role in this mucosa remains to 
be elucidated. 
Among other findings, we also showed that the presence of the urothelium caused a 
parallel rightward shift in the concentration-response curve to isoproterenol, together with a 
significantly greater reduction in the pEC50 value of urothelium-intact compared to 
urothelium-denuded strips. These results may suggest that stimulation of β-adrenoceptors in 
the human urothelium induces the release of a urothelium-derived factor which inhibits the 
relaxation response of the detrusor strips to isoproterenol. On the other hand, we also 
showed that the presence of the urothelium did not significantly inhibit the maximal 
relaxant response of the human detrusor strips to isoproterenol. This apparent discrepancy 
might be accounted for by the assumption that the strong direct relaxant effects of 
isoproterenol at the high concentrations used in this study masked the effect of the 
inhibitory factor. In this regard, Murakami and colleagues reported that the urothelium was 
not involved in the relaxation responses of the porcine bladder to isoproterenol, but that the 
presence of isoproterenol caused a parallel rightward shift of the concentration-response 
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curve to carbachol (Murakami et al. 2007). This discrepancy between these past and present 
results may be due to the different baselines used to measure the relaxant effect to 
isoproterenol, namely passive (resting) tension versus active (carbachol-pre-contracted) 
tension. Here, we did not use a pre-contraction agent such as carbachol out of concern that 
these might mask the effects of a urothelium-derived factor induced by stimulation of the 
urothelial β-adrenoceptors. Moreover, given recent studies showing the presence and 
functional effects of muscarinic receptor subtypes in the human urothelium and 
suburothelial myofibroblasts (Hawthorn et al. 2000; Chaiyaprasithi et al. 2003; Mukerji G 
et al. 2006; Tyagi S et al. 2006), carbachol might influence urothelial β-adrenoceptor 
function via urothelial/suburothelial muscarinic receptor signaling. On the other hand, the 
present study is also limited by the possibility that a urothelium-derived factor or the 
urothelium itself might have influenced the relaxant effects of isoproterenol on the 
urothelium-intact detrusor strips. Clarification of this possibility may require further studies 
to identify the functional role of human urothelial β-adrenoceptors. 
In rats, β-adrenoceptor stimulation activates the adenylate cyclase pathway in bladder 
epithelial cells and initiates an increase in intracellular Ca2+ concentration, thereby 
triggering NO production and its release (Birder et al. 1998, 2002). This finding led us to 
speculate that urothelial-derived NO can directly or indirectly modulate detrusor smooth 
muscle function. However, our results unexpectedly showed that L-NAME, a NO synthase 
inhibitor, had no significant attenuating effect on the responses to isoproterenol in human 
urothelium-intact detrusor smooth muscle. Murakami and colleagues also reported that 
NG-nitro-L-arginine (L-NNA), a NO synthase inhibitor, did not prevent the enhanced 
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inhibitory effects of isoproterenol in urothelium-intact porcine bladder (Murakami et al. 
2007). While soluble guanylate cyclase is the target enzyme of NO and activation of this 
enzyme produces an increase in tissue levels of cyclic guanosine monophosphate (cGMP) 
(Mayer et al. 1994), some reports state that soluble guanylate cyclase does not exist in 
detrusor smooth muscle cells (Smet et al. 1996; Fathian-Sabot et al. 2001). These findings 
suggest that urothelial β-adrenoceptor-induced release of NO might not be involved in the 
relaxant effects on human detrusor smooth muscle. 
In summary, we identified the presence of β1-, β2-, and β3-adrenoceptors in human 
urinary bladder urothelium, as has been also observed in detrusor smooth muscle. In 
addition, we also found that the relaxant effect of isoproterenol on detrusor smooth muscle 
was reduced in the presence of the urothelium in humans. It is possible that β-adrenoceptor 
agonists stimulate the release of an unidentified inhibitory factor from the urothelium that 
reduces detrusor relaxation induced by β-adrenoceptor stimulation; however, further work 
is needed to elucidate the exact mechanisms involved.
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 Table 1 Primer sequences for RT-PCR of β-adrenoceptor subtypes and β-actin 
Code Primer sequence (5’ → 3’) GenBank accession No. 
β1-AR Sense: TCGTGTGCACCGTGTGGGCC NM_000684 
 Anti-sense: AGGAAACGGCGCTCGCAGCTGTCG  
β2-AR Sense: GCCTGCTGACCAAGAATAAGGCC NM_000024 
 Anti-sense: CCCATCCTGCTCCACCT  
β3-AR Sense: GCTCCGTGGCCTCACGAGAA NM_000025 
 Anti-sense: CCCAACGGCCAGTGGCCAGTCAGCG  
β-actin Sense: GCTCG CGTCGACAACGGCTC NM_001101 
 Anti-sense: CAAACATGATCTGGGTCATCTTCTC  
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Figure legends 
 
Fig. 1 Agarose gel electrophoresis shows expression of β1-, β2- and β3-adrenoceptor mRNA in the human urinary bladder 
urothelium (a) and detrusor smooth muscle (b) obtained from four different patients (#1 - #4). Expected size of PCR 
products for β1-, β2- and β3-adrenoceptor was 265, 329 and 314 bp, respectively. PCR products for the urothelial 
β-adrenoceptors were digested with specific restriction enzymes, namely β1-adrenoceptor with Rsa I (c: generated 
fragments of 67 and 198 bp), β2-adrenoceptor with Rsa I (d: 93 and 236 bp) and β3-adrenoceptor with Apa I (e: 123 and 
191 bp in lane 2, 4, 6 and 8; β3-adrenoceptor PCR products in lane 1, 3, 5 and 7). Expression of mRNA for α-SMA, a 
smooth muscle marker, was high in human detrusor smooth muscle RNA (Musc), but undetectable in human urothelium 
RNA (Uroth) (f); 100 bp marker (MK).  
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Fig. 2 Immunohistochemistry of human urinary bladder with rabbit polyclonal antibody showing positive (brown) 
staining of (a) β1-, (b) β2- and (c) β3-adrenoceptor in human urinary bladder urothelial cells, and positive staining of (d) 
β1-, (e) β2- and (f) β3-adrenoceptor in detrusor smooth muscle cells. Negative control of the human urinary bladder 
urothelium (g) and detrusor smooth muscle (h) showed no positive staining. Bar: (a)-(h) = 100 µm. 
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Fig. 3 Representative traces showing the effect of isoproterenol on the resting tension of human detrusor strips without (a) 
or with (b) an intact urothelium. Phentolamine (1 µM) was present in all experiments to inhibit α-adrenoceptors. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Concentration-response curves of human detrusor strips to isoproterenol with (n=9) and without an intact 
urothelium (n=7). All experiments were performed in the presence of 1 µM phentolamine. Data are expressed as a 
percentage of maximal relaxation induced with 10 µM forskolin. An asterisk indicates P < 0.05 vs. urothelium-denuded 
strip responses. 
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Fig. 5 Concentration-response curves of urothelium-intact human detrusor strips to isoproterenol in the presence (n=5) 
and absence (n=9) of 100 µM L-NAME. All experiments were performed in the presence of 1 µM phentolamine. Data are 
expressed as a percentage of the maximal relaxation induced by 10 µM forskolin. 
